| Dr Tatiana Silva Sousa, MD | |
|
5301 Davis Ln Ste 100, Austin, TX 78749-4061 | |
| (512) 615-2730 | |
| (512) 309-7024 |
| Full Name | Dr Tatiana Silva Sousa |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 15 Years |
| Location | 5301 Davis Ln Ste 100, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427292937 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | P6922 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Westlake Dermatology Pa | 6305817230 | 40 |
News Archive
IES, a leading national provider of electrical and communications systems and services for the commercial, industrial and residential markets, announced today that its commercial business group has been awarded a contract from Manhattan Torcon JV to install the electrical systems for the Level 4 bio-safety lab (BSL-4) replacement facility at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick in Frederick, Md.
Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI), the leader in email encryption services, today announced that Humana renewed its contract with ZixCorp. This latest agreement is a two-year extension of Humana's original agreement which has now spanned seven successful years.
Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma.
Ipsen and Inspiration Biopharmaceuticals, Inc. announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia.
› Verified 7 days ago
| Entity Name | Westlake Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518939347 PECOS PAC ID: 6305817230 Enrollment ID: O20040804000774 |
News Archive
IES, a leading national provider of electrical and communications systems and services for the commercial, industrial and residential markets, announced today that its commercial business group has been awarded a contract from Manhattan Torcon JV to install the electrical systems for the Level 4 bio-safety lab (BSL-4) replacement facility at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick in Frederick, Md.
Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI), the leader in email encryption services, today announced that Humana renewed its contract with ZixCorp. This latest agreement is a two-year extension of Humana's original agreement which has now spanned seven successful years.
Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma.
Ipsen and Inspiration Biopharmaceuticals, Inc. announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia.
› Verified 7 days ago
| Entity Name | Oliver Street 5.01(a) Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457695413 PECOS PAC ID: 0042464125 Enrollment ID: O20130128000189 |
News Archive
IES, a leading national provider of electrical and communications systems and services for the commercial, industrial and residential markets, announced today that its commercial business group has been awarded a contract from Manhattan Torcon JV to install the electrical systems for the Level 4 bio-safety lab (BSL-4) replacement facility at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick in Frederick, Md.
Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI), the leader in email encryption services, today announced that Humana renewed its contract with ZixCorp. This latest agreement is a two-year extension of Humana's original agreement which has now spanned seven successful years.
Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma.
Ipsen and Inspiration Biopharmaceuticals, Inc. announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tatiana Silva Sousa, MD 5301 Davis Ln Ste 100, Austin, TX 78749-4061 Ph: (512) 615-2730 | Dr Tatiana Silva Sousa, MD 5301 Davis Ln Ste 100, Austin, TX 78749-4061 Ph: (512) 615-2730 |
News Archive
IES, a leading national provider of electrical and communications systems and services for the commercial, industrial and residential markets, announced today that its commercial business group has been awarded a contract from Manhattan Torcon JV to install the electrical systems for the Level 4 bio-safety lab (BSL-4) replacement facility at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick in Frederick, Md.
Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI), the leader in email encryption services, today announced that Humana renewed its contract with ZixCorp. This latest agreement is a two-year extension of Humana's original agreement which has now spanned seven successful years.
Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma.
Ipsen and Inspiration Biopharmaceuticals, Inc. announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia.
› Verified 7 days ago
Dr. John Joseph Ghidoni Iii, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8229 Shoal Creek Blvd, Suite#101, Austin, TX 78757 Phone: 512-371-7400 Fax: 512-371-7488 | |
Moise Levy, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 200, Austin, TX 78723 Phone: 512-628-1920 Fax: 512-628-1921 | |
Dr. Susan Elizabeth Dozier, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8240 N Mo Pac Expwy, Suite 355, Austin, TX 78759 Phone: 512-527-9020 Fax: 512-527-9000 | |
Dr. Gregory A. Nikolaidis, Dermatology Medicare: Medicare Enrolled Practice Location: 8825 Bee Cave Rd, Suite 100, Austin, TX 78746 Phone: 512-328-3376 Fax: 512-399-6895 | |
Amy Ayres Mcclung, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9701 Brodie Ln Ste 106, Austin, TX 78748 Phone: 512-280-3939 Fax: 512-280-3938 | |
Stanley Tyler Hollmig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1601 Trinity St Ste 704b, Austin, TX 78712 Phone: 512-324-7468 Fax: 512-324-7469 | |
Dr. Lauren Piilani Rimoin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8825 Bee Caves Rd Ste 100, Austin, TX 78746 Phone: 512-328-3376 Fax: 512-666-3767 |